HiberGene Diagnostics
Latest round
- Series A
Last raised
- Feb 2015
Total raised
- $2.3M
Investors
- 2
About HiberGene Diagnostics
HiberGene Diagnostics Limited, founded in 2009 in Dublin, Ireland, specializes in diagnostic solutions for infectious diseases.HiberGene Diagnostics specializes in the development and manufacture of advanced diagnostic tests for human infectious diseases, primarily utilizing its proprietary LAMP technology. The company’s flagship products include rapid diagnostic tests for meningitis, specifically targeting the two prevalent forms—Meningococcus and Pneumococcal Meningitis. These tests provide highly sensitive and timely detection of the disease, facilitating prompt treatment in clinical settings.HiberGene Diagnostics operates within the USD 57 billion in-vitro diagnostics market, generating revenue through the sales of its innovative diagnostic products. The company primarily engages in B2B transactions, selling its tests through partnerships with healthcare institutions and distributors. Revenue is derived from direct sales to hospitals and laboratories, allowing for efficient testing of infectious diseases. The company is working towards expanding its reach into additional markets in Asia and North America by late 2023, which will facilitate greater accessibility to its diagnostic tools and improve patient care in these regions.
Who invested in HiberGene Diagnostics
2 investors across 1 round
See all investors in HiberGene Diagnostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 2, 2015
Amount
$2.3M
Investors
Questions about HiberGene Diagnostics
Who invested in HiberGene Diagnostics?
HiberGene Diagnostics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HiberGene Diagnostics raised?
HiberGene Diagnostics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did HiberGene Diagnostics last raise money?
HiberGene Diagnostics's most recent round on record is a Series A, in Feb 2015.
What does HiberGene Diagnostics do?
HiberGene Diagnostics Limited, founded in 2009 in Dublin, Ireland, specializes in diagnostic solutions for infectious diseases.
Where is HiberGene Diagnostics headquartered?
HiberGene Diagnostics is headquartered in Dublin, Ireland.
Which VCs invest in companies like HiberGene Diagnostics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at HiberGene Diagnostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like HiberGene Diagnostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.